Merck and Samsung Bioepis Enter Biosimilars Agreement

News   Feb 21, 2013

 
Merck and Samsung Bioepis Enter Biosimilars Agreement
 
 
 
 

RELATED ARTICLES

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

READ MORE

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE